Novartis Pharma S.p.A. (manufacturing, quality control, primary and secondary packaging, batch release)

Ukraine

All drugs from this manufacturer

  • UPERIO

    The drug is intended for the treatment of adult patients with chronic heart failure presenting with reduced left ventricular ejection fraction.

    Dosage form: tablets, film-coated

    Active substance Dosage
    sacubitril 24.3 mg
    valsartan 25.7 mg

    ATC: C09DX04

  • UPERIO

    The drug is intended for the treatment of adult patients with chronic heart failure accompanied by reduced left ventricular ejection fraction.

    Dosage form: tablets, film-coated

    Active substance Dosage
    sacubitril 48.6 mg
    valsartan 51.4 mg

    ATC: C09DX04

  • UPERIO

    The drug is used for the treatment of adult patients with chronic heart failure accompanied by reduced left ventricular ejection fraction.

    Dosage form: tablets, film-coated

    Active substance Dosage
    sacubitril 97.2 mg
    valsartan 102.8 mg

    ATC: C09DX04